MABWELL (SHANGHAI) BIOSCIENCEMABWELL (SHANGHAI) BIOSCIENCEMABWELL (SHANGHAI) BIOSCIENCE

MABWELL (SHANGHAI) BIOSCIENCE

No trades
See on Supercharts
Market capitalization
‪13.88 B‬CNY
−2.64CNY
‪−1.05 B‬CNY
‪124.04 M‬CNY
‪276.32 M‬
Beta (1Y)
1.17

About MABWELL (SHANGHAI) BIOSCIENCE

CEO
Da Tao Liu
Headquarters
Shanghai
Employees (FY)
‪1.49 K‬
Founded
2017
ISIN
CNE100005RD2
FIGI
BBG00YLZ63R2
Mabwell (Shanghai) Bioscience Co., Ltd. engages in the research and development, production and sales of therapeutic biological products. Its main product is antibody drugs. Its platform covered antibody drug discovery, pharmaceutical development, quality research control and assurance, medical and clinical operations, and commercial base. The company was founded on May 12, 2017 and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 688062 is 35.61 CNY — it has increased by 1.77% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange MABWELL (SHANGHAI) BIOSCIENCE stocks are traded under the ticker 688062.
688062 stock is 3.35% volatile and has beta coefficient of 1.17. Check out the list of the most volatile stocks — is MABWELL (SHANGHAI) BIOSCIENCE there?
Yes, you can track MABWELL (SHANGHAI) BIOSCIENCE financials in yearly and quarterly reports right on TradingView.
688062 stock has risen by 13.59% compared to the previous week, the month change is a 4.77% rise, over the last year MABWELL (SHANGHAI) BIOSCIENCE has showed a 48.68% increase.
688062 net income for the last quarter is ‪−380.15 M‬ CNY, while the quarter before that showed ‪−259.76 M‬ CNY of net income which accounts for −46.34% change. Track more MABWELL (SHANGHAI) BIOSCIENCE financial stats to get the full picture.
Today MABWELL (SHANGHAI) BIOSCIENCE has the market capitalization of ‪13.98 B‬, it has increased by 3.33% over the last week.
No, 688062 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 688062 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MABWELL (SHANGHAI) BIOSCIENCE stock right from TradingView charts — choose your broker and connect to your account.
688062 reached its all-time high on Mar 14, 2024 with the price of 37.00 CNY, and its all-time low was 12.96 CNY and was reached on Oct 11, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has ‪1.49 K‬ employees. See our rating of the largest employees — is MABWELL (SHANGHAI) BIOSCIENCE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MABWELL (SHANGHAI) BIOSCIENCE technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MABWELL (SHANGHAI) BIOSCIENCE stock shows the buy signal. See more of MABWELL (SHANGHAI) BIOSCIENCE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MABWELL (SHANGHAI) BIOSCIENCE EBITDA is ‪−983.16 M‬ CNY, and current EBITDA margin is −788.90%. See more stats in MABWELL (SHANGHAI) BIOSCIENCE financial statements.